January 20, 2026 · Form 4 insider transaction
Kelley Shannon T sold 429 shares of Madrigal Pharmaceuticals, Inc. at $501.40 per share, a transaction worth $215.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024.